Article Text
Papers
Management of reflux disease
Abstract
The management of reflux disease can be divided into three major phases, the first being diagnosis and severity assessment, the second, prompt initial control of symptoms, and the third, selection of a long term management approach that is tailored to meet individual patient needs and preferences. Throughout these phases of management, the major priorities should include achieving patient satisfaction and minimising management costs.
- diagnosis
- reflux disease
- severity assessment
- symptom control
- symptom evaluation
- H2RA, H2 receptor antagonist
- PPI, proton pump inhibitor
Statistics from Altmetric.com
Footnotes
-
Conflict of interest: This symposium was sponsored by AstraZeneca, makers of omeprazole. The author of this paper has received sponsorship for travel and an honorarium from AstraZeneca.